Literature DB >> 12757279

The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?

Haiden A Huskamp1, Arnold M Epstein, David Blumenthal.   

Abstract

Several recent bills in Congress to add a Medicare prescription drug benefit would allow the use of formularies to control costs. However, there is little empirical evidence of the impact of formularies among elderly and disabled populations. We assess the effect of a closed formulary implemented by the Veterans Health Administration (VHA) in 1997 on drug prices, market share, and drug spending. We find that the VHA National Formulary was effective at shifting prescribing behavior toward the selected drugs, achieving sizable price reductions from manufacturers, and greatly decreasing drug spending.

Mesh:

Year:  2003        PMID: 12757279     DOI: 10.1377/hlthaff.22.3.149

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  13 in total

1.  Principles for evidence-based drug formulary policy.

Authors:  Gregory E Simon; Bruce M Psaty; Jennifer Berg Hrachovec; Marc Mora
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

2.  Reform of prescription drug reimbursement and pricing in the German social health insurance market: a comparison of three scenarios.

Authors:  Stefan Gress; Dea Niebuhr; Uwe May; Jürgen Wasem
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 3.  Principles of economics crucial to pharmacy students' understanding of the prescription drug market.

Authors:  Gail B Rattinger; Rahul Jain; Jing Ju; C Daniel Mullins
Journal:  Am J Pharm Educ       Date:  2008-06-15       Impact factor: 2.047

4.  Canadian list of essential medications: Potential and uncertainties.

Authors:  Navindra Persaud; Haroon Ahmad
Journal:  Can Fam Physician       Date:  2017-04       Impact factor: 3.275

5.  Effects of Guideline and Formulary Changes on Statin Prescribing in the Veterans Affairs.

Authors:  Adam A Markovitz; Rob G Holleman; Timothy P Hofer; Eve A Kerr; Mandi L Klamerus; Jeremy B Sussman
Journal:  Health Serv Res       Date:  2017-12       Impact factor: 3.402

6.  A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.

Authors:  Rajan Ragupathy; Katri Aaltonen; June Tordoff; Pauline Norris; David Reith
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

7.  A Prescription for Drug Formulary Evaluation: An Application of Price Indexes.

Authors:  Jacob Glazer; Haiden A Huskamp; Thomas G McGuire
Journal:  Forum Health Econ Policy       Date:  2012-03-30

8.  Health care for patients with serious mental illness: family medicine's role.

Authors:  Nancy E Morden; Lisa A Mistler; William B Weeks; Stephen J Bartels
Journal:  J Am Board Fam Med       Date:  2009 Mar-Apr       Impact factor: 2.657

9.  Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications.

Authors:  Colin R Dormuth; Peter Neumann; Malcolm Maclure; Robert J Glynn; Sebastian Schneeweiss
Journal:  Med Care       Date:  2009-05       Impact factor: 2.983

10.  Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison.

Authors:  Walid F Gellad; Julie M Donohue; Xinhua Zhao; Maria K Mor; Carolyn T Thorpe; Jeremy Smith; Chester B Good; Michael J Fine; Nancy E Morden
Journal:  Ann Intern Med       Date:  2013-07-16       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.